The 2009 Influenza A (H1N1) Pandemic: Perceptions and Use of Neuraminidase Inhibitors among French Physicians (notice n° 1051955)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02079cam a2200241 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250127020137.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Barthe, Juliette |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | The 2009 Influenza A (H1N1) Pandemic: Perceptions and Use of Neuraminidase Inhibitors among French Physicians |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2011.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 98 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The purpose of this study is to describe the perception of neuraminidase inhibitors (NAIs) during the pandemic A(H1N1)2009 influenza among general practitioners. A survey was conducted between 15 July and 15 September 2010 among a random sample of metropolitan French GPs. Among the 161 respondents, only 6% reported that they "often" prescribed NAIs during the pandemic A(H1N1)2009 influenza, while 69% reported that they prescribed NAIs "from time to time". The main objectives of GPs were to limit the risk of complications and the duration of symptoms. The main predictor of prescription of neuraminidase inhibitors during the pandemic A(H1N1)2009 influenza was the prescription of NAIs during epidemic seasonal periods (OR = 3.23 [95% CI 1.3 to 8.8]). Barriers to the prescription of NAIs were an estimated lack of efficacy (64%) and a negative benefit/risk balance (52%). Among the GPs surveyed in this research, 62% reported that they had been vaccinated against influenza A(H1N1)2009, while 73% recommended vaccination. GPs who prescribed NAIs during the pandemic A(H1N1)2009 influenza were those who prescribed NAIs during a seasonal influenza epidemic. To improve the outpatient prescription of NAIs during pandemic outbreaks, more knowledge about NAIs is required during seasonal influenza. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | neuraminidase inhibitors |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | H1N1 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | family practice |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pandemic |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | influenza |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Noyelle, Clémence |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Partouche, Henri |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Santé Publique | 23 | 4 | 2011-10-17 | p. 305-315 | 0995-3914 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-sante-publique-2011-4-page-305?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-sante-publique-2011-4-page-305?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux